Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Optinose Inc (OPTN)

Optinose Inc (OPTN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Optinose Inc 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 USA

www.optinose.com P: 267-364-3500 F: 267-395-2119

Description:

OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and AVP-825 which are in clinical stage. OptiNose Inc. is headquartered in Pennsylvania, USA.

Key Statistics

Overview:

Market Capitalization, $K 126,604
Enterprise Value, $K 183,154
Shares Outstanding, K 113,039
Annual Sales, $ 70,990 K
Annual Net Income, $ -35,480 K
Last Quarter Sales, $ 19,860 K
Last Quarter Net Income, $ -9,970 K
EBIT, $ -22,740 K
EBITDA, $ -20,670 K
60-Month Beta -0.10
% of Insider Shareholders 2.20%
% of Institutional Shareholders 85.60%
Float, K 110,552
% Float 97.80%
Short Volume Ratio 0.66

Growth:

1-Year Return -34.41%
3-Year Return -65.00%
5-Year Return -87.79%
5-Year Revenue Growth 904.10%
5-Year Earnings Growth 88.06%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.09 on 03/07/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm -0.32
EPS Growth vs. Prev Qtr -12.50%
EPS Growth vs. Prev Year 47.06%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OPTN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -33.05%
Profit Margin % -49.98%
Debt/Equity -1.50
Price/Sales 1.66
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.77
Interest Coverage -0.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar